Treatment and Renal Outcomes Up to 96 Weeks After Tenofovir Alafenamide Switch From Tenofovir Disoproxil Fumarate in Routine Practice-Reference-Cited by-同舟云学术

Treatment and Renal Outcomes Up to 96 Weeks After Tenofovir Alafenamide Switch From Tenofovir Disoproxil Fumarate in Routine Practice

Published:2021-05-22 Issue:2 Volume:74 Page:656-666
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Toyoda Hidenori¹,Leong Jennifer²,Landis Charles³^ORCID,Atsukawa Masanori⁴,Watanabe Tsunamasa⁵,Huang Daniel Q.⁶⁷,Liu Joanne³⁸,Quek Sabrina Xin Zi⁹,Ishikawa Toru¹⁰,Arai Taeang⁴,Yokohama Keisuke¹¹,Chuma Makoto¹²,Takaguchi Koichi¹³,Uojima Haruki¹⁴,Senoo Tomonori¹³,Dang Hansen¹⁵,Maeda Mayumi¹⁵,Hoang Joseph¹⁵,Le Richard H.¹⁵,Yasuda Satoshi¹,Thin Khin N.¹⁵,Tran Sally¹⁵,Chien Nicholas¹⁵,Henry Linda¹⁵,Asai Akira¹¹^ORCID,Fukunishi Shinya¹⁶,Cheung Ramsey¹⁵¹⁷,Lim Seng Gee⁶⁷^ORCID,Trinh Huy N.¹⁸,Nguyen Mindie H.¹⁵^ORCID

Affiliation:

1. Department of Gastroenterology and Hepatology Ogaki Municipal Hospital Ogaki Japan

2. Henry D. Janowitz Division of Gastroenterology Mt. Sinai Health System New York NY

3. Division of Gastroenterology University of Washington Seattle WA

4. Division of Gastroenterology and Hepatology Nippon Medical School Tokyo Japan

5. Division of Gastroenterology and Hepatology St. Marianna University School of Medicine Kawasaki Japan

6. Division of Gastroenterology and Hepatology Department of Medicine National University Hospital Singapore

7. Department of Medicine Yong Loo Lin School of MedicineNational University of Singapore Singapore

8. University of Washington Seattle WA

9. Department of Medicine National University Hospital Singapore

10. Department of Gastroenterology Saiseikai Niigata Hospital Niigata Japan

11. 2nd Department of Internal Medicine Osaka Medical College Osaka Japan

12. Gastroenterological Center Yokohama City University Medical Center Yokohama Japan

13. Department of Hepatology Kagawa Prefectural Central Hospital Kagawa Japan

14. Department of Gastroenterology, Internal Medicine Kitasato University School of Medicine Sagamihara Japan

15. Division of Gastroenterology and Hepatology Stanford University Medical Center Palo Alto CA

16. Premier Development Research of Medicine Osaka Medical College Osaka Japan

17. Division of Gastroenterology and Hepatology The Palo Alto Veterans Affairs Health Care System Palo Alto CA

18. San Jose Gastroenterology San Jose CA

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.31793

Reference24 articles.

1. Prevalence of Chronic Hepatitis B Virus Infection in the United States

2. World Health Organization.Draft global health sector strategies Viral hepatitis 2016‐2021. Sixty‐Ninth World Health Assembly Provisional agenda item 15.1. April2016;A69/32.

3. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study

4. Changing incidence of reported viral hepatitis in China from 2004 to 2016: an observational study

5. Hepatitis B Virus: Advances in Prevention, Diagnosis, and Therapy

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improvement of hepatic fibrosis after tenofovir disoproxil fumarate switching to tenofovir alafenamide for three years;World Journal of Hepatology;2024-07-27

2. Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patient with chronic hepatitis B;Journal of Gastroenterology and Hepatology;2024-05

3. Lipid metabolism and renal function changes switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide therapy in CHB patients;2024-04-02

4. Noninferiority Outcomes of Besifovir Compared to Tenofovir Alafenamide in Treatment-Naïve Patients with Chronic Hepatitis B;Gut and Liver;2024-01-12

5. Real‐world safety and effectiveness of tenofovir alafenamide for 144 weeks in Japanese patients with chronic hepatitis B;Journal of Viral Hepatitis;2024-01